{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:57:22Z","timestamp":1773334642705,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10620-025-09450-9","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T03:43:36Z","timestamp":1759203816000},"page":"1041-1048","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Uncovering the Mechanisms of Failure of Proton Pump Inhibitors in GERD: The Role of Esophageal Acid Sensitivity"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9642-864X","authenticated-orcid":false,"given":"Jerry D.","family":"Gardner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4233-3773","authenticated-orcid":false,"given":"George","family":"Triadafilopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"9450_CR1","doi-asserted-by":"publisher","unstructured":"Yadlapati R, Gyawali CP, Pandolfino JE on behalf of the CGIT GERD Consensus Conference Participants. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review. Clinical Gastroenterology and Hepatology 2022;20:984\u2013994.https:\/\/doi.org\/10.1016\/j.cgh.2022.01.025.","DOI":"10.1016\/j.cgh.2022.01.025"},{"key":"9450_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/nmo.12236","volume":"26","author":"N DeBortoli","year":"2014","unstructured":"DeBortoli N, Martinucci I, Savarino E et al. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil 2014;26:28\u201335. https:\/\/doi.org\/10.1111\/nmo.12236.","journal-title":"Neurogastroenterol Motil"},{"key":"9450_CR3","doi-asserted-by":"publisher","unstructured":"Allgood LD, Grender JM, Shaw MJ, Peura DA. Comparison of Prilosec OTCTM (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburn. Journal of Clinical Pharmacy and Therapeutics. 2005; 30:105\u2013112. https:\/\/doi.org\/10.1111\/j.1365-2710.2004.00620.x.","DOI":"10.1111\/j.1365-2710.2004.00620.x"},{"key":"9450_CR4","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.cgh.2023.10.025","volume":"22","author":"L Laine","year":"2024","unstructured":"Laine L, Spechler S, Yadlapati R et al. Vonoprazan is Efficacious for Treatment of Heartburn in Nonerosive Reflux Disease: A Randomized Trial. Clinical Gastroenterology and Hepatology 2024;22:2211\u20132220. https:\/\/doi.org\/10.1016\/j.cgh.2023.10.025.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"9450_CR5","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","volume":"67","author":"CP Gyawali","year":"2018","unstructured":"Gyawali CP, Kahrilas PJ, Savarino E et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67:1351\u20131362. https:\/\/doi.org\/10.1136\/gutjnl-2017-314722.","journal-title":"Gut."},{"key":"9450_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5056\/jnm20030","volume":"26","author":"M Ghisa","year":"2020","unstructured":"Ghisa M, Barberio B, Savarino V et al. The Lyon Consensus: Does It Differ From the Previous Ones? J Neurogastroenterol Motil. 2020;26:311\u2013321. https:\/\/doi.org\/10.5056\/jnm20030.","journal-title":"J Neurogastroenterol Motil."},{"key":"9450_CR7","doi-asserted-by":"publisher","unstructured":"Gardner JD. The relationship between esophageal acidity and symptom frequency in symptomatic nonerosive gastroesophageal reflux disease. Physiological Reports, 10, e15442. https:\/\/doi.org\/10.14814\/phy2.15442.","DOI":"10.14814\/phy2.15442"},{"key":"9450_CR8","doi-asserted-by":"publisher","DOI":"10.32388\/IJUE1J.2","author":"JD Gardner","year":"2022","unstructured":"Gardner JD. Oscillating esophageal acid sensitivity in symptomatic reflux hypersensitivity and functional heartburn. Qeios. 2022. https:\/\/doi.org\/10.32388\/IJUE1J.2.","journal-title":"Qeios"},{"key":"9450_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1046\/j.1365-2036.2002.01158.x","volume":"16","author":"JD Gardner","year":"2002","unstructured":"Gardner JD, Perdomo C, Sloan S et al. Integrated acidity and rabeprazole pharmacology. Aliment. Pharmacol. Ther. 2002;16:455\u2013464. https:\/\/doi.org\/10.1046\/j.1365-2036.2002.01158.x.","journal-title":"Aliment. Pharmacol. Ther."},{"key":"9450_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1046\/j.1365-2036.2003.01533.x","volume":"17","author":"JD Gardner","year":"2003","unstructured":"Gardner JD, Sloan S, Miner PB Jr, Robinson M. Meal-stimulated gastric acid secretion and integrated gastric acidity in gastroesophageal reflux disease. Aliment Pharmacol Ther. 2003;17:945\u2013953. https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01533.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9450_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1046\/j.1365-2036.2003.01532.x","volume":"17","author":"JD Gardner","year":"2003","unstructured":"Gardner JD, Sloan S, Miner PB Jr, Robinson M. Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastroesophageal reflux disease treated with a proton pump inhibitor. Aliment Pharmacol Ther. 2003;17:954\u2013964. https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01532.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9450_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1365-2036.2003.01644.x","volume":"18","author":"JD Gardner","year":"2003","unstructured":"Gardner JD, Sloan S, Robinson M, Miner PB Jr. Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux patients treated with a proton pump inhibitor. Aliment Pharmacol Ther. 2003;18:133\u2013140. https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01644.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9450_CR13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1046\/j.1365-2036.2003.01785.x","volume":"18","author":"JD Gardner","year":"2003","unstructured":"Gardner JD, Gallo-Torres H, Sloan S, Robinson M, Miner PB Jr. The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis. Aliment Pharmacol Ther. 2003;18:891\u2013905. https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01785.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9450_CR14","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/j.1365-2036.2004.02278.x","volume":"20","author":"JD Gardner","year":"2004","unstructured":"Gardner JD, Sloan S, Robinson M, Miner PB. Oesophageal pH has a power-law distribution in control and gastro-oesophageal reflux disease subjects. Aliment Pharmacol Ther. 2004;20:1373\u20131379. https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02278.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9450_CR15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1111\/j.1365-2036.2004.02279.x","volume":"20","author":"JD Gardner","year":"2004","unstructured":"Gardner JD, Sloan S, Robinson M, Miner PB. Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor. Aliment Pharmacol Ther. 2004;20:1381\u20131386. https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02279.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9450_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1365-2036.2005.02665.x","volume":"22","author":"JD Gardner","year":"2005","unstructured":"Gardner JD, Young W, Sloan S, Robinson M, Miner PB Jr. The fractal nature of human gastro-oesophageal reflux. Aliment Pharmacol Ther. 2005;22:823\u2013830. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02665.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9450_CR17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/0016-5085(88)90162-x","volume":"95","author":"DJ Hetzel","year":"1988","unstructured":"Hetzel DJ, Dent J, Reed WD et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903\u2013912. https:\/\/doi.org\/10.1016\/0016-5085(88)90162-x.","journal-title":"Gastroenterology"},{"key":"9450_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1365-2036.2006.02811.x","volume":"23","author":"JD Gardner","year":"2006","unstructured":"Gardner JD, Young W, Sloan S, Robinson M, Miner PB Jr. The effects of changing temperature correction factors on measures of acidity calculated from gastric and oesophageal pH recordings. Aliment Pharmacol Ther. 2006;23:629\u2013638. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.02811.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9450_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under the Receiver Operating Characteristic (ROC) curve. Radiology. 1982;143:29\u201336. https:\/\/doi.org\/10.1148\/radiology.143.1.7063747.","journal-title":"Radiology."},{"key":"9450_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u2013845. https:\/\/doi.org\/10.2307\/2531595.","journal-title":"Biometrics."},{"key":"9450_CR21","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.29.25330512","author":"JD Gardner","year":"2025","unstructured":"Gardner JD, Triadafilopoulos G. Esophageal acid and symptom frequency in GERD phenotypes: a quadrant-based analysis of subject-level variation. medRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.06.29.25330512.","journal-title":"medRxiv"},{"key":"9450_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/1097-0142(1950)3:1<32:AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:26. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1%3c32:AID-CNCR2820030106%3e3.0.CO;2-3.","journal-title":"Cancer."},{"key":"9450_CR23","first-page":"129","volume-title":"Intuitive Biostatistics","author":"H Motulsky","year":"1995","unstructured":"Motulsky H. Interpreting Lab Tests. In New York: Oxford University Press; 1995; 129\u2013139."},{"key":"9450_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nyas.14501","volume":"1486","author":"P Sharma","year":"2021","unstructured":"Sharma P, Yadlapati R. Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid. Ann N Y Acad Sci. 2021;1486:3\u201314. https:\/\/doi.org\/10.1111\/nyas.14501.","journal-title":"Ann N Y Acad Sci."},{"key":"9450_CR25","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1056\/NEJMra200028","volume":"383","author":"R Mittal","year":"2020","unstructured":"Mittal R, Vaezi MF. Esophageal motility disorders and gastroesophageal reflux disease. New Eng J Med 2020;383:1961\u20131972. https:\/\/doi.org\/10.1056\/NEJMra200028.","journal-title":"New Eng J Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09450-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09450-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09450-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:11:01Z","timestamp":1773292261000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09450-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["9450"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09450-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}